AMSTERDAM, Sept 30: An experimental Roche drug that seems to work particularly well against lung cancer in smokers may be a ‘game changer’ for these normally difficult-to-treat patients, researchers said yesterday. Presenting detailed data from an early-stage trial of the drug, called MPDL3280A, in patients with a form of the disease called non-small cell lung cancer (NSCLC), investigators said what they had found was ‘great news for lung cancer patients’. (agencies)
Follow our WhatsApp channel